<DOC>
	<DOCNO>NCT00894660</DOCNO>
	<brief_summary>The study determine amodiaquine tablet ( Pfizer ) , antimalaria agent , pharmaceutically equivalent comparator product ( Arsuamoon-Guilin China ) .</brief_summary>
	<brief_title>A Bioequivalence Study Comparing Amodiaquine Tablet ( Pfizer ) To Amodiaquine Tablets ( Arsuamoon-Guilin China ) In Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Amodiaquine</mesh_term>
	<criteria>Healthy male and/or female subject age 21 55 year , inclusive . BMI 18 30 kg/m2 ; total body weight &gt; 45 kg ( 99 lb ) . An informed consent document sign date subject legally acceptable representative . Evidence history clinically significant abnormality . A positive urine drug screen , history regular alcohol consumption .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Bioequivalence , Healthy Volunteers</keyword>
</DOC>